Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2010
03/25/2010US20100076465 Fibrin-based nerve repair conduit and method of producing the same
03/25/2010US20100076188 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome
03/25/2010US20100076088 Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it
03/25/2010US20100076087 Methods of reduction of interpatient variability
03/25/2010US20100076086 Process for the preparation of o-desmethyl venlafaxine
03/25/2010US20100076085 HCl Polymorphs of 3-((2-(Dimethylamino)methyl-(cyclohex-1-yl))phenol
03/25/2010US20100076079 Pharmaceutical Compositions Of Short-Acting Sedative Hypnotic Agent
03/25/2010US20100076075 Methods of treating neurological disease using antagonists of the nmda receptor complex
03/25/2010US20100076074 Carbamate reducers of skeletal muscle tension
03/25/2010US20100076073 Combination of an NMDA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders
03/25/2010US20100076068 Aminoalcohol Derivatives and Their Therapeutic Use
03/25/2010US20100076037 Methods of Treating Neuropathic Pain with Agonists of PPAR-gamma
03/25/2010US20100076036 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
03/25/2010US20100076029 Compounds Which Selectively Modulate The CB2 Receptor
03/25/2010US20100076027 Indazole or 4,5,6,7-tetrahydro-indazole derivatives
03/25/2010US20100076024 Novel Compounds as Serine Protease Inhibitors
03/25/2010US20100076016 Isoquinolinone derivatives as nk3 antagonists
03/25/2010US20100076011 Enantiomer-Pure Hexahydro-Pyrrolocyclopenta-Pyridine Derivatives
03/25/2010US20100076010 Alpha 1a-adrenoceptor antagonists
03/25/2010US20100076007 Polymorphs of 6-Beta-Naltrexol
03/25/2010US20100076004 Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
03/25/2010US20100076000 Sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents
03/25/2010US20100075994 Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
03/25/2010US20100075992 Tetrodotoxin and its derivatives for the treament of peripheral-nervously derived neuropathi pain
03/25/2010US20100075989 Novel Compounds Having Selective Inhibiting Effect at GSK3
03/25/2010US20100075986 Oxophenyl-Cyclohexyl-Propanolamine Derivatives, Production And Use Thereof In Therapeutics
03/25/2010US20100075981 such as N-{trans-4-[2-(4-Isoxazolo[4,5-c]pyridin-3-yl-piperazin-1-yl)-ethyl]-cyclohexyl}-acetamide, used for the therapeutic and/or prophylactic treatment of cognitive disorders, psychological disorders, drug abuse and drug dependence
03/25/2010US20100075978 Sulfonamide derivatives as bradykinin antagonists
03/25/2010US20100075976 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
03/25/2010US20100075975 Medicament for the enhancement of cognitive function and neuroprotection
03/25/2010US20100075972 Agent for treatment of multiple sclerosis
03/25/2010US20100075968 Imidazolidine Carboxamide Derivatives as P2X7 Modulators
03/25/2010US20100075964 Imidazole based lxr modulators
03/25/2010US20100075959 Benzothiazole derivatives with activity as adenosine receptor ligands
03/25/2010US20100075957 Aminodihydrothiazine derivatives substituted with a cyclic group
03/25/2010US20100075955 Short-acting benzodiazepine salts and their polymorphic forms
03/25/2010US20100075954 Substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives
03/25/2010US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
03/25/2010US20100075950 Phenylpropanone modulators of dopamine receptor
03/25/2010US20100075938 Use of Chemical Chelators as Reversal Agents for Drug-Induced Neuromuscular Block
03/25/2010US20100075932 Novel salicylic anilides
03/25/2010US20100075931 Substituted oxazole ketone modulators of fatty acid amide hydrolase
03/25/2010US20100075920 Small molecule stimulators of neuronal growth
03/25/2010US20100075916 Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases
03/25/2010US20100075912 Novel morphine derivatives
03/25/2010US20100075910 Synthetic peptide amides and dimeric forms thereof
03/25/2010US20100075898 N-terminal vdac variants and uses thereof
03/25/2010US20100074976 Novel agents for the treatment of disorders connected to impaired neurotransmission
03/25/2010US20100074973 Thioxanthene modulators of dopamine d2 receptors
03/25/2010US20100074959 Lipid growth factor formulations
03/25/2010US20100074955 Combination of NMDA-Receptor Ligand and a Compound With 5-HT6 Receptor Affinity
03/25/2010US20100074952 Tasted masked veterinary solid compositions
03/25/2010US20100074948 Method of producing fast dissolving tablets
03/25/2010US20100074944 Transdermal Tobacco Alkaloid Reservoir Patch
03/25/2010US20100074907 Methods for Promoting Myelination, Neuronal Survival and Oligodendrocyte Differentiation Via Administration of SP35 or TrkA Antagonists
03/25/2010US20100074900 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
03/25/2010US20100074899 Methods for treating conditions associated with masp-2 dependent complement activation
03/25/2010US20100074875 Composition containing human umbilical cord blood-derived mesenchymal stem cell for inducing differentiation and proliferation of neural precursor cells or neural stem cells to neural cells
03/25/2010US20100074852 Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by pbr, cb2, and nk2 receptors
03/25/2010DE102008047515A1 Use of histone deacetylase inhibitor for the preparation of a medicament for prophylaxis and/or treatment of demyelinating disease, preferably autoimmune neuropathy, Guillain-Barre syndrome, acute inflammatory demyelinating polyneuropathy
03/25/2010CA2737740A1 5-oxazolidin-2-one substituted 1,3,8-triazaspiro [4.5] decan-4-one derivatives useful as orl-1 receptor modulators
03/25/2010CA2737463A1 Freeze-dried powder preparation of tetrodotoxin and the producing method thereof
03/25/2010CA2737074A1 Methods for treating progressive multiple sclerosis
03/25/2010CA2737038A1 Amide compounds, compositions and uses thereof
03/25/2010CA2734333A1 Pegylated opioids with low potential for abuse
03/24/2010EP2166745A2 Bit mask generation system and printer drivers and printing methods incorporating bit masks generated utilising same
03/24/2010EP2166744A2 Bit mask generation system and printer drivers and printing methods incorporating bit masks generated utilising same
03/24/2010EP2166087A2 FAD4, FAD5, FAD5-2 et FAD6, fatty acid desaturase family members and uses thereof
03/24/2010EP2166010A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
03/24/2010EP2166009A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
03/24/2010EP2166008A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
03/24/2010EP2166003A1 Excitatory amino acid receptor antagonists
03/24/2010EP2164865A2 Compounds for the modulation of huntingtin aggregation, methods and means for identifying such compounds
03/24/2010EP2164847A1 3-aza-bicyclo[3.3.0]octane compounds
03/24/2010EP2164838A1 Novel compound
03/24/2010EP2164837A1 Novel compounds
03/24/2010EP2164834A2 Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture
03/24/2010EP2164572A2 Carbamoyl-cyclohexanes for treating acute mania
03/24/2010EP2164519A2 Long-acting polymeric prodrugs of exendin
03/24/2010EP2164509A1 Igf for the treatment of rett syndrome and synaptic disorders
03/24/2010EP2164500A1 The use of zeburaline for the treatment of autoimmune diseases or immune rejection of transplants
03/24/2010EP2164499A1 Treatment of tardive dyskinesia with pyridoxal 5'-phosphate
03/24/2010EP2164494A1 Methods of treatment
03/24/2010EP2164492A1 (thio) -carbamoyl-cyclohexane derivatives and method for treating schizophrenia
03/24/2010EP2164490A1 Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain.
03/24/2010EP2164483A2 Transglutaminase inhibitor comprising chlorogenic acid and a method for producing thereof
03/24/2010EP2164479A2 New sigma-receptor ligands with anti-apoptotic and/or pro-apoptotic properties over cellular biochemical mechanisms, with neuroprotective, anti- cancer, anti-metastatic and anti-(chronic) inflammatory action
03/24/2010EP2164325A1 Oxyimino compounds and the use thereof
03/24/2010EP2046791B1 Urea derivatives of tropane, their preparation and their therapeutic application
03/24/2010EP1789404B1 Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
03/24/2010EP1745047B1 Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine adenosine-a2a- receptor antagonists
03/24/2010EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/24/2010EP1315506B1 Phospholipid derivatives of valproic acid and mixtures thereof
03/24/2010EP1180938B1 Agents, compositions and methods utilizing the same useful in treating or preventing alzheimer disease
03/24/2010EP1009399B1 Gaba analogs to prevent and treat gastrointestinal damage
03/24/2010CN101679951A Telencephalic glial-restricted cell populations and related compositions and methods
03/24/2010CN101679457A Piperazine and [1,4] diazepan derivatives as NK antagonists
03/24/2010CN101679435A New compounds 892
03/24/2010CN101679430A 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the ORL-i receptor for the treatment of anxiety and depression
03/24/2010CN101679425A 6-(pyrrolopyridinyl)-pyrimidine-2-yl-amine derivatives
1 ... 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 ... 1833